Belite Bio, Inc
BLTENasdaqCIK 1889109HealthcareFiscal year ends Dec 31
Reports and events: 61 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-04-0320:14 ET | 6-K | Report of a foreign private issuerPeriod 2023-03-31 | 0001104659-23-040395 |
| 2023-03-3116:02 ET | 20-F | Annual report of a foreign private issuerPeriod 2022-12-31 | 0001104659-23-040145 |
| 2022-12-1316:01 ET | 6-K | Report of a foreign private issuerPeriod 2022-12-13 | 0001104659-22-126599 |
| 2022-11-1808:00 ET | 6-K | Report of a foreign private issuerPeriod 2022-11-18 | 0001104659-22-120070 |
| 2022-10-0306:02 ET | 6-K | Report of a foreign private issuerPeriod 2022-10-01 | 0001104659-22-104829 |
| 2022-09-1608:06 ET | 6-K | Report of a foreign private issuerPeriod 2022-09-16 | 0001104659-22-100641 |
| 2022-08-2208:00 ET | 6-K | Report of a foreign private issuerPeriod 2022-08-22 | 0001104659-22-093109 |
| 2022-08-1121:48 ET | 6-K | Report of a foreign private issuerPeriod 2022-08-10 | 0001104659-22-088899 |
| 2022-07-1916:05 ET | 6-K | Report of a foreign private issuerPeriod 2022-07-19 | 0001104659-22-080840 |
| 2022-05-1216:34 ET | 6-K | Report of a foreign private issuerPeriod 2022-05-12 | 0001104659-22-059486 |
| 2022-05-0307:04 ET | 6-K | Report of a foreign private issuerPeriod 2022-05-31 | 0001104659-22-055003 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:16 ET. Listed shows no prices and gives no investment advice.